| Study | Exclusion reasons | Rmk | Reference |
|---|---|---|---|
| Geissbuhler, 2018 | inadequate or absent control group |
Geissbuhler, Y. Therapeutic Advances in Neurological Disorders 2018; 11:217-. 10.1177/1756286418804760 |
|
| Gajofatto, 2015 | inadequate or absent control group |
Gajofatto Drug Healthc Patient Saf 2015; 7:157-67 10.2147/DHPS.S69640 |
|
| Illoh, 2018 | other reason |
Illoh Pharmacoepidemiol Drug Saf 2018; 27:604-611 10.1002/pds.4409 |
-
About
-
Master protocol
-
Browse exposition
-
RSS
-
Made with in Lyon
-
Contact us
-
Privacy policy
-
